De Novellis, D.; Fontana, R.; Giudice, V.; Serio, B.; Selleri, C.
Innovative Anti-CD38 and Anti-BCMA Targeted Therapies in Multiple Myeloma: Mechanisms of Action and Resistance. Int. J. Mol. Sci. 2023, 24, 645.
https://doi.org/10.3390/ijms24010645
AMA Style
De Novellis D, Fontana R, Giudice V, Serio B, Selleri C.
Innovative Anti-CD38 and Anti-BCMA Targeted Therapies in Multiple Myeloma: Mechanisms of Action and Resistance. International Journal of Molecular Sciences. 2023; 24(1):645.
https://doi.org/10.3390/ijms24010645
Chicago/Turabian Style
De Novellis, Danilo, Raffaele Fontana, Valentina Giudice, Bianca Serio, and Carmine Selleri.
2023. "Innovative Anti-CD38 and Anti-BCMA Targeted Therapies in Multiple Myeloma: Mechanisms of Action and Resistance" International Journal of Molecular Sciences 24, no. 1: 645.
https://doi.org/10.3390/ijms24010645
APA Style
De Novellis, D., Fontana, R., Giudice, V., Serio, B., & Selleri, C.
(2023). Innovative Anti-CD38 and Anti-BCMA Targeted Therapies in Multiple Myeloma: Mechanisms of Action and Resistance. International Journal of Molecular Sciences, 24(1), 645.
https://doi.org/10.3390/ijms24010645